[1]
J. C. Sutadji, A. D. W. Widodo, and D. N. Indiastuti, “Mortality Comparison of Using Anti Interleukin-6 Therapy and Using Standard Treatment in Severe Covid-19”, FMI, vol. 57, no. 2, pp. 158–165, Jun. 2021.